Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 16.7M | 10.7M | 12.7M | 16.2M |
Cost of revenue | 2.4M | 2.0M | 2.5M | 2.8M |
Gross profit | 14.3M | 8.6M | 10.2M | 13.4M |
Operating expense | ||||
Research & development | 23.1M | 21.9M | 20.9M | 23.8M |
Selling general and admin | 2.3M | 2.3M | 934K | 2.4M |
Other operating expenses | -1.8M | -1.8M | -2.4M | -2.0M |
Operating income | -9.6M | -14.2M | -10.7M | -10.8M |
Non operating interest income | ||||
Income | 2.2M | 2.9M | 3.6M | 3.0M |
Expense | 2.1M | 1.9M | 1.9M | 1.9M |
Other income expense | -14.3M | -4.9M | 15.3M | -13.3M |
Pretax income | -23.7M | -18.1M | 6.4M | -23.1M |
Tax provision | 0 | 0 | 514K | -59K |
Net income | -23.7M | -18.1M | 5.9M | -23.1M |
Basic EPS | — | -0.2 | — | -0.2 |
Diluted EPS | — | -0.2 | — | -0.2 |
Basic average shares | — | 100.2M | — | 100.1M |
Diluted average shares | — | 100.2M | — | 100.1M |
EBITDA | -2.4M | -6.3M | -1.1M | -3.2M |
Net income from continuing op. | -23.7M | -18.1M | 5.9M | -23.1M |
Minority interests | — | — | 0 | 0 |
Preferred stock dividends | — | — | — | — |